Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Cancer Causes Control. 2020 May 11;31(7):683–689. doi: 10.1007/s10552-020-01313-0

Table 2.

Factors associated with tumor deposit status (present vs absent) of incident colorectal cancers in National Cancer Database diagnosed during 2010–2014

OR 95% CI P
All tumor
 MSI (Unstable/High vs Stable/Low) 0.84 (0.75 to 0.95) 0.004
KRAS (Mutated vs Wild type) 1.11 (1.02 to 1.20) 0.015
 Location (Rectal vs Colonic) 1.14 (0.99 to 1.30) 0.064
 Age (65+ vs <65 year) 0.85 (0.78 to 0.92) <0.001
 Pathologic stage (III-IV vs I-II) 14.44 (12.51 to 16.66) <0.001
 Tumor grade (High vs Low) 1.58 (1.45 to 1.73) <0.001
Early stage tumor (stage I-II)
 MSI (Unstable/High vs Stable/Low) 0.87 (0.61 – 1.25) 0.454
KRAS (Mutated vs Wild type) 1.49 (1.13 – 1.97) 0.005
 Location (Rectal vs Colonic) 1.13 (0.77 – 1.65) 0.545
 Age (65+ vs <65 year) 0.71 (0.54 – 0.95) 0.020
 Tumor grade (High vs Low) 1.83 (1.30 – 2.57) 0.001
Late stage tumor (stage III-IV)
 MSI (Unstable/High vs Stable/Low) 0.84 (0.74 – 0.95) 0.004
KRAS (Mutated vs Wild type) 1.08 (0.99 – 1.17) 0.100
 Location (Rectal vs Colonic) 1.14 (0.98 – 1.31) 0.080
 Age (65+ vs <65 year) 0.86 (0.79 – 0.94) 0.001
 Tumor grade (High vs Low) 1.57 (1.43 – 1.72) <0.001

P of multivariable logistic regression analysis; MSI, microsatellite instability; OR, odds ratio; CI, confidence intervals. Race, sex and Charlson-Deyo Score were not linked to tumor deposit status.